Pelvic inflammatory disease and oral contraceptive use.
Feldblum
P J
PJ
Burton
N
N
Rosenberg
M J
MJ
D000349:Africa; D001695:Biology; D002584:Cervix Uteri; D002689:Chlamydia; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003906:Developing Countries; D004194:Disease; D005193:Family Planning Services; D005835:Genitalia; D005836:Genitalia, Female; D007239:Infections; D000292:Pelvic Inflammatory Disease; D010827:Physiology; D012749:Sexually Transmitted Diseases; D014566:Urogenital System; D014599:Uterus
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral
Adnexitis--etiology; Africa; Biology; Cervical Effects; Cervix; Chlamydia--etiology; Contraception; Contraceptive Agents, Female--beneficial effects; Contraceptive Agents, Female--side effects; Contraceptive Agents--beneficial effects; Contraceptive Agents--side effects; Contraceptive Methods--beneficial effects; Contraceptive Methods--side effects; Developing Countries; Diseases; Family Planning; Genitalia; Genitalia, Female; Infections; Literature Review; Oral Contraceptives--beneficial effects; Oral Contraceptives--side effects; Pelvic Infections--etiology; Pelvic Inflammatory Disease; Physiology; Reproductive Tract Infections; Sexually Transmitted Diseases; Urogenital System; Uterus